AP2936A - Long term treatment of HIV-infection with TMC278 - Google Patents

Long term treatment of HIV-infection with TMC278

Info

Publication number
AP2936A
AP2936A AP2008004535A AP2008004535A AP2936A AP 2936 A AP2936 A AP 2936A AP 2008004535 A AP2008004535 A AP 2008004535A AP 2008004535 A AP2008004535 A AP 2008004535A AP 2936 A AP2936 A AP 2936A
Authority
AP
ARIPO
Prior art keywords
tmc278
hiv
infection
long term
term treatment
Prior art date
Application number
AP2008004535A
Other languages
English (en)
Other versions
AP2008004535A0 (en
Inventor
Lieven Elvire Colette Baert
Guenter Kraus
Gerben Albert Eleutherius Van T Klooster
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36446113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2936(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AP2008004535A0 publication Critical patent/AP2008004535A0/xx
Application granted granted Critical
Publication of AP2936A publication Critical patent/AP2936A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2008004535A 2006-01-20 2007-01-19 Long term treatment of HIV-infection with TMC278 AP2936A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100677 2006-01-20
PCT/EP2007/050516 WO2007082922A2 (en) 2006-01-20 2007-01-19 Long term treatment of hiv- infection with tcm278

Publications (2)

Publication Number Publication Date
AP2008004535A0 AP2008004535A0 (en) 2008-08-31
AP2936A true AP2936A (en) 2014-07-31

Family

ID=36446113

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004535A AP2936A (en) 2006-01-20 2007-01-19 Long term treatment of HIV-infection with TMC278

Country Status (28)

Country Link
US (3) US10953009B2 (da)
EP (1) EP1981506B3 (da)
JP (2) JP5754005B2 (da)
KR (2) KR101562943B1 (da)
CN (2) CN101370504A (da)
AP (1) AP2936A (da)
AR (1) AR059097A1 (da)
AU (1) AU2007206901B2 (da)
BR (1) BRPI0707179A2 (da)
CA (1) CA2636436C (da)
CY (1) CY1114089T1 (da)
DK (1) DK1981506T6 (da)
EA (1) EA014914B1 (da)
ES (1) ES2414982T7 (da)
HK (1) HK1125828A1 (da)
HR (1) HRP20130544T4 (da)
IL (1) IL192132A (da)
ME (1) ME01617B (da)
MY (1) MY150717A (da)
NZ (1) NZ569347A (da)
PL (1) PL1981506T6 (da)
PT (1) PT1981506E (da)
RS (1) RS52821B2 (da)
SG (1) SG170073A1 (da)
SI (1) SI1981506T1 (da)
TW (1) TWI458483B (da)
UA (1) UA96436C2 (da)
WO (1) WO2007082922A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
SI2040671T1 (en) * 2006-06-23 2018-05-31 Janssen Sciences Ireland Uc Water suspensions TMC278
AU2014200819B2 (en) * 2006-06-23 2016-05-26 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
AU2016219555B2 (en) * 2006-06-23 2017-08-10 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
CL2008000746A1 (es) 2007-03-14 2008-09-22 Tibotec Pharm Ltd Composicion farmaceutica en solucion que comprende tmc278 y un polimero soluble en agua; proceso de preparacion de dicha composicion; y uso de un polvo que comprende tmc278 para tratar sida.
SG196774A1 (en) * 2008-12-24 2014-02-13 Tibotec Pharm Ltd Implantable devices for treating hiv
PL2480220T3 (pl) * 2009-09-22 2015-10-30 Janssen Sciences Ireland Uc Leczenie i zapobieganie zakażeniu HIV
ES2600878T3 (es) 2009-12-21 2017-02-13 Janssen Sciences Ireland Uc Implante removible, degradable, para la liberación prolongada de un compuesto activo
NZ627826A (en) * 2010-01-27 2016-01-29 Viiv Healthcare Co Antiviral combinations involving (3s,11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
TWI577377B (zh) 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
US9266824B2 (en) 2014-01-13 2016-02-23 Warsaw Orthopedic, Inc. Methods and compositions for making an amino acid triisocyanate
WO2017084973A1 (en) * 2015-11-16 2017-05-26 Evonik Röhm Gmbh Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
US20190163877A1 (en) * 2017-11-27 2019-05-30 International Business Machines Corporation Decision support for effective long-term drug therapy
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021001A1 (en) * 2003-09-03 2005-03-10 Tibotec Pharmaceuticals Ltd. Combinations of a pyrimidine containing nnrti with rt inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US6568805B1 (en) * 2001-11-26 2003-05-27 Dan L. Dietz Trust Magnetic buckle for eyeglasses
US7094413B2 (en) * 2002-01-24 2006-08-22 Sangstat Medical Corporation Combined therapy for treatment of HIV infection
ES2371442T7 (es) 2004-09-02 2022-05-12 Janssen Pharmaceutica Nv Sal de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrilo
CA2577288C (en) * 2004-09-02 2010-11-30 Janssen Pharmaceutica N.V. Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021001A1 (en) * 2003-09-03 2005-03-10 Tibotec Pharmaceuticals Ltd. Combinations of a pyrimidine containing nnrti with rt inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUSMAN E.: "RETROVIRUSES AND OPPORTUNISTIC INFECTIONS", IDRUGS, CURRENT DRUGS LTD., GB, vol. 8, no. 4, 2005, pages 299-302, XP008051947, ISSN: 1369-7056, page 300, column 2, paragraph 2 *

Also Published As

Publication number Publication date
EA200870183A1 (ru) 2009-12-30
KR101501475B1 (ko) 2015-03-19
US20210177843A1 (en) 2021-06-17
ES2414982T3 (es) 2013-07-23
PT1981506E (pt) 2013-06-25
DK1981506T3 (da) 2013-06-24
WO2007082922A3 (en) 2007-09-20
AP2008004535A0 (en) 2008-08-31
JP2013100338A (ja) 2013-05-23
EP1981506B3 (en) 2021-06-09
EP1981506A2 (en) 2008-10-22
NZ569347A (en) 2011-07-29
KR101562943B1 (ko) 2015-10-23
RS52821B (en) 2013-10-31
RS52821B2 (sr) 2021-07-30
US20110275654A1 (en) 2011-11-10
EA014914B1 (ru) 2011-02-28
DK1981506T6 (da) 2021-06-14
EP1981506B1 (en) 2013-03-27
MY150717A (en) 2014-02-28
JP5754005B2 (ja) 2015-07-22
HRP20130544T4 (hr) 2021-08-20
SI1981506T1 (sl) 2013-08-30
IL192132A (en) 2014-05-28
CN101370504A (zh) 2009-02-18
TWI458483B (zh) 2014-11-01
UA96436C2 (ru) 2011-11-10
CY1114089T1 (el) 2016-07-27
AU2007206901A1 (en) 2007-07-26
WO2007082922A2 (en) 2007-07-26
ES2414982T7 (es) 2021-11-05
HRP20130544T1 (en) 2013-07-31
SG170073A1 (en) 2011-04-29
JP2009526758A (ja) 2009-07-23
JP5836983B2 (ja) 2015-12-24
PL1981506T6 (pl) 2021-07-12
TW200806295A (en) 2008-02-01
CN103877091A (zh) 2014-06-25
HK1125828A1 (en) 2009-08-21
BRPI0707179A2 (pt) 2011-04-26
US10953009B2 (en) 2021-03-23
PL1981506T3 (pl) 2013-08-30
AR059097A1 (es) 2008-03-12
WO2007082922A8 (en) 2008-01-03
KR20140141699A (ko) 2014-12-10
AU2007206901B2 (en) 2013-01-31
ME01617B (me) 2014-09-20
US20240226099A1 (en) 2024-07-11
IL192132A0 (en) 2009-08-03
KR20080085194A (ko) 2008-09-23
CA2636436A1 (en) 2007-07-26
CA2636436C (en) 2014-04-01

Similar Documents

Publication Publication Date Title
AP2936A (en) Long term treatment of HIV-infection with TMC278
HUE037639T2 (hu) Pimavanszerin együttes beadása más szerekkel
HK1117039A1 (en) Prevention of hiv-infection with tmc278
EP2287155A4 (en) ACYLTHIOURE COMPOUND OR SALT THEREOF, AND USE OF THE COMPOUND OR SALT
PT1945243E (pt) Utilização da calcitonina para o tratamento da ar
GB0506835D0 (en) Therapeutic use of nefopam
GB0702931D0 (en) Skin application
GB0909297D0 (en) Composition for the treatment of skin conditions
HK1161122A1 (en) Use of 24-norudca 24-norudca
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
GB0515703D0 (en) Therapeutic use of nefopam
GB0602857D0 (en) The treatment of sialorrhoea
GB0601091D0 (en) The Treatment Of Ocular Conditions
GB0602858D0 (en) The treatment of sialorrhoea
GB0602855D0 (en) The Treatment Of Sialorrhoea
HU0700758D0 (en) The basic of biocomputer and the possible realization thereof
GB0625602D0 (en) Treatment of sialorrhoea
GB0521338D0 (en) Full length body shower
TJ20050863A (en) The way of narcotism treatment
GB0722338D0 (en) Novel use and treatment
GB0603076D0 (en) The treatment of hyperhidrosis
GB0603074D0 (en) The treatment of hyperhidrosis
GB0625603D0 (en) The treatment of hyperhidrosis
GB0603075D0 (en) The treatment of hyperhidrosis